Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients - real world evidence analysis.
Journal Information
Full Title: Ann Hematol
Abbreviation: Ann Hematol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declarations Conflict of interestsAuthors declare no conflict of interest. SupportThis work was supported by grant of the Ministry of Health of the Czech Republic NU21-03–00076, by grant of Ministry of Health DRO (FNBr, 65269705), by the project National Institute for Cancer Research (Programme EXCELES, ID Project No. LX22NPO5102)—Funded by the European Union – Next Generation EU. Conflict of interests Authors declare no conflict of interest."
Funding Disclosure
Evidence found in paper:
"Funding Open access publishing supported by the National Technical Library in Prague."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025